(Q47965646)

7 February 2018

title

Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001). (English)

1 reference

7 February 2018

1 reference

N G Rainov

1

1 reference

7 February 2018

V Heidecke

series ordinal

2

1 reference

7 February 2018

publication date

1 January 2004

1 reference

7 February 2018

Journal of Neuro-Oncology

published in

1 reference

7 February 2018

volume

66

1 reference

7 February 2018

issue

1-2

1 reference

7 February 2018

page(s)

197-201

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1023/b:neon.0000013478.27604.01

exact match

0 references

cites work

Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

1 reference

12 December 2020

Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.

1 reference

12 December 2020

Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata

1 reference

12 December 2020

Interleukin-13 receptor as a unique target for anti-glioblastoma therapy

1 reference

12 December 2020

Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein

1 reference

12 December 2020

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

1 reference

12 December 2020

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

1 reference

12 December 2020

Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.

1 reference

12 December 2020

1 reference

12 December 2020

Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma.

1 reference

12 December 2020

Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy

1 reference

12 December 2020

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

12 December 2020

10.1023/B:NEON.0000013478.27604.01

Identifiers

DOI

1 reference

7 February 2018

Dimensions Publication ID

1012426943

0 references

Fatcat ID

release_oq723vnjofdc7nyjshx2zjpvmm

0 references

PubMed ID

15015787

1 reference

7 February 2018